search
Back to results

Psychological Intervention for Relapse Prevention in First Episode Schizophrenia

Primary Purpose

Schizophrenic Disorders

Status
Unknown status
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
cognitive behavioural therapy
psychoeducation
Sponsored by
University Hospital Tuebingen
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Schizophrenic Disorders focused on measuring schizophrenia, first episode, cognitive behavioural therapy, psychoeducation

Eligibility Criteria

18 Years - 55 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: diagnosis of schizophrenic disorder according to ICD 10: F20 first episode age between 18 and 55 willingness to give informed consent also to a double blind pharmacological treatment study Exclusion Criteria: residence outside of the catchment area insufficient knowledge of the German language substance abuse or addiction as primary clinical problem serious physical illness organic brain disease pregnancy contraindications to neuroleptic treatment

Sites / Locations

  • Department of Psychiatry and Psychotherapy, University of Bonn
  • Department of Psychiatry and Psychotherapy, University of Cologne
  • Department of Psychiatry and Psychotherapy, University of Duesseldorf
  • Department of Psychiatry and Psychotheray, University of Muenchen
  • Department of Psychiatry and Psychotherapy, University of Tuebingen

Outcomes

Primary Outcome Measures

relapse

Secondary Outcome Measures

quantitative measures of symptoms
social functioning
cognitive functioning
quality of life

Full Information

First Posted
September 8, 2005
Last Updated
September 8, 2005
Sponsor
University Hospital Tuebingen
search

1. Study Identification

Unique Protocol Identification Number
NCT00161408
Brief Title
Psychological Intervention for Relapse Prevention in First Episode Schizophrenia
Official Title
Psychological Intervention for Relapse Prevention in First Episode Schizophrenia
Study Type
Interventional

2. Study Status

Record Verification Date
September 2005
Overall Recruitment Status
Unknown status
Study Start Date
December 2000 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
September 2005 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
University Hospital Tuebingen

4. Oversight

5. Study Description

Brief Summary
The study is a randomized clinical trial investigating the efficacy of a comprehensive psychological intervention for the treatment of first episode schizophrenia
Detailed Description
Patients suffering from their first episode of schizophrenic disorders are randomly allocated to either a short "information centered psychoeducation" (ICP) of 8 sessions or a "cognitive behavioral treatment" (CBT). CBT includes 8 sessions of psychoeducation, 8 sessions of computer based cognitive training, 8 sessions with relatives and 20 sessions of focusing on stress management, relapse prevention and coping with persistent symptoms. The primary endpoint is relapse at the one and two year follow up.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Schizophrenic Disorders
Keywords
schizophrenia, first episode, cognitive behavioural therapy, psychoeducation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
106 (false)

8. Arms, Groups, and Interventions

Intervention Type
Behavioral
Intervention Name(s)
cognitive behavioural therapy
Intervention Type
Behavioral
Intervention Name(s)
psychoeducation
Primary Outcome Measure Information:
Title
relapse
Secondary Outcome Measure Information:
Title
quantitative measures of symptoms
Title
social functioning
Title
cognitive functioning
Title
quality of life

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: diagnosis of schizophrenic disorder according to ICD 10: F20 first episode age between 18 and 55 willingness to give informed consent also to a double blind pharmacological treatment study Exclusion Criteria: residence outside of the catchment area insufficient knowledge of the German language substance abuse or addiction as primary clinical problem serious physical illness organic brain disease pregnancy contraindications to neuroleptic treatment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stefan Klingberg, PD Dr. phil. Dipl. Psych.
Organizational Affiliation
University Hospital Tuebingen
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Psychiatry and Psychotherapy, University of Bonn
City
Bonn
ZIP/Postal Code
53105
Country
Germany
Facility Name
Department of Psychiatry and Psychotherapy, University of Cologne
City
Cologne
ZIP/Postal Code
50924
Country
Germany
Facility Name
Department of Psychiatry and Psychotherapy, University of Duesseldorf
City
Duesseldorf
ZIP/Postal Code
40629
Country
Germany
Facility Name
Department of Psychiatry and Psychotheray, University of Muenchen
City
Muenchen
ZIP/Postal Code
80336
Country
Germany
Facility Name
Department of Psychiatry and Psychotherapy, University of Tuebingen
City
Tuebingen
ZIP/Postal Code
72076
Country
Germany

12. IPD Sharing Statement

Learn more about this trial

Psychological Intervention for Relapse Prevention in First Episode Schizophrenia

We'll reach out to this number within 24 hrs